Gemphire Therapeutics Inc. (GEMP): Price and Financial Metrics
Gemphire Therapeutics Inc. (GEMP)
Today's Latest Price: $0.30 USD
Updated Dec 30 7:35pm
Add GEMP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
GEMP Stock Price Chart Interactive Chart >
GEMP Price/Volume Stats
| Current price | $0.30 | 52-week high | $1.49 |
| Prev. close | $0.30 | 52-week low | $0.24 |
| Day low | $0.29 | Volume | 191,000 |
| Day high | $0.34 | Avg. volume | 127,174 |
| 50-day MA | $0.34 | Dividend yield | N/A |
| 200-day MA | $0.71 | Market Cap | 4.46M |
Gemphire Therapeutics Inc. (GEMP) Company Bio
Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of dyslipidemia cardiovascular disease. The company was founded in 2008 and is headquartered in Northville, Michigan.
Loading social stream, please wait...